Growth hormone prevents the development of autoimmune diabetes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 48, 2013, Pages

  Villares, Ricardo ^a   Kakabadse, Dimitri ^a   Juarranz, Yasmina ^b   Gomariz, Rosa P ^b   Martínez A, Carlos ^a   Mellado, Mario ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Beta cells; Tregs

Indexed keywords

GROWTH HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL DESTRUCTION; CELL DIFFERENTIATION; CELL FUNCTION; CELL INFILTRATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; TH1 CELL; TH17 CELL;

BETA CELLS; TREGS;

ADOPTIVE TRANSFER; ANIMALS; CYTOKINES; DIABETES MELLITUS, TYPE 1; FLOW CYTOMETRY; GROWTH HORMONE; IMMUNOHISTOCHEMISTRY; INSULIN-SECRETING CELLS; MACROPHAGES; MICE; MICE, TRANSGENIC; PRODROMAL SYMPTOMS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84888358648     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1314985110     Document Type: Article

References (68)

1. Gonzalo JA, et al. (1996) Enterotoxin septic shock protection and deficient T helper 2 cytokine production in growth hormone transgenic mice. J Immunol 157(8): 3298-3304.
2. Cross RJ, Bryson JS, Roszman TL (1992) Immunologic disparity in the hypopituitary dwarf mouse. J Immunol 148(5): 1347-1352.
3. Murphy WJ, Durum SK, Anver MR, Longo DL (1992) Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice. J Immunol 148(12): 3799-3805.
4. Dardenne M, Mello-Coelho V, Gagnerault MC, Postel-Vinay MC (1998) Growth hormone receptors and immunocompetent cells. Ann N Y Acad Sci 840: 510-517.
5. Postel-Vinay MC, de Mello Coelho V, Gagnerault MC, Dardenne M (1997) Growth hormone stimulates the proliferation of activated mouse T lymphocytes. Endocrinology 138(5): 1816-1820.
6. Yoshida A, Ishioka C, Kimata H, Mikawa H (1992) Recombinant human growth hormone stimulates B cell immunoglobulin synthesis and proliferation in serum-free medium. Acta Endocrinol (Copenh) 126(6): 524-529.
7. Merchav S, Tatarsky I, Hochberg Z (1988) Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone. J Clin Invest 81(3): 791-797.
8. Takagi K, Suzuki F, Barrow RE, Wolf SE, Herndon DN (1998) Recombinant human growth hormone modulates Th1 and Th2 cytokine response in burned mice. Ann Surg 228(1): 106-111.
9. DiFedele LM, et al. (2005) Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitis. Gastroenterology 128(5): 1278-1291.
10. Han X, et al. (2007) Tumour necrosis factor alpha blockade induces an antiinflammatory growth hormone signalling pathway in experimental colitis. Gut 56(1): 73-81.
11. Murawski MR, Litherland SA, Clare-Salzler MJ, Davoodi-Semiromi A (2006) Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: Implications for the NOD STAT5B mutation in diabetes pathogenesis. Ann N Y Acad Sci 1079: 198-204.
12. King C, Sarvetnick N (2011) The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions. PLoS ONE 6(2):e17049.
13. Pollard KM (2012) Gender differences in autoimmunity associated with exposure to environmental factors. J Autoimmun 38(2-3):J177-J186.
14. Driver JP, Serreze DV, Chen Y-G (2011) Mouse models for the study of autoimmune type 1 diabetes: A NOD to similarities and differences to human disease. Semin Immunopathol 33(1): 67-87.
15. Heit JJ, Karnik SK, Kim SK (2006) Intrinsic regulators of pancreatic beta-cell proliferation. Annu Rev Cell Dev Biol 22: 311-338.
16. Nielsen JH, Svensson C, Galsgaard ED, Møldrup A, Billestrup N (1999) Beta cell proliferation and growth factors. J Mol Med (Berl) 77(1): 62-66.
17. McGrane MM, et al. (1990) Developmental regulation and tissue-specific expression of a chimaeric phosphoenolpyruvate carboxykinase/bovine growth hormone gene in transgenic animals. J Reprod Fertil Suppl 41: 17-23.
18. Olsson B, et al. (2005) Bovine growth hormone transgenic mice are resistant to dietinduced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet. Endocrinology 146(2): 920-930.
19. Vasavada RC, et al. (2000) Targeted expression of placental lactogen in the beta cells of transgenic mice results in beta cell proliferation, islet mass augmentation, and hypoglycemia. J Biol Chem 275(20): 15399-15406.
20. Smaniotto S, et al. (2005) Growth hormone modulates thymocyte development in vivo through a combined action of laminin and CXC chemokine ligand 12. Endocrinology 146(7): 3005-3017.
21. Lin MS, et al. (2011) A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice. Immunol Res 50(2-3): 213-220.
22. Martin-Orozco N, et al. (2009) T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 31(5): 787-798.
23. Charré S, et al. (2002) Abnormalities in dendritic cell and macrophage accumulation in the pancreas of nonobese diabetic (NOD) mice during the early neonatal period. Histol Histopathol 17(2): 393-401.
24. Wu Y, et al. (2011) Growth hormone receptor regulates β cell hyperplasia and glucose- stimulated insulin secretion in obese mice. J Clin Invest 121(6): 2422-2426.
25. Valera A, et al. (1993) Glucose metabolism in transgenic mice containing a chimeric Penolpyruvate carboxykinase/bovine growth hormone gene. FASEB J 7(9): 791-800.
26. Winer S, et al. (2003) Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive. Nat Med 9(2): 198-205.
27. Nakayama M, et al. (2005) Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435(7039): 220-223.
28. Kent SC, et al. (2005) Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 435(7039): 224-228.
29. Brode S, Raine T, Zaccone P, Cooke A (2006) Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. J Immunol 177(10): 6603-6612.
30. Komatsu N, Hori S (2007) Full restoration of peripheral Foxp3+ regulatory T cell pool by radioresistant host cells in scurfy bone marrow chimeras. Proc Natl Acad Sci USA 104(21): 8959-8964.
31. D'Alise AM, et al. (2008) The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc Natl Acad Sci USA 105(50): 19857-19862.
32. Gregori S, Giarratana N, Smiroldo S, Adorini L (2003) Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol 171(8): 4040-4047.
33. Kim D-H, et al. (2011) Inhibition of autoimmune diabetes by TLR2 tolerance. J Immunol 187(10): 5211-5220.
34. Tarbell KV, Yamazaki S, Steinman RM (2006) The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity. Semin Immunol 18(2): 93-102.
35. You S, et al. (2008) Immunoregulatory pathways controlling progression of autoimmunity in NOD mice. Ann N Y Acad Sci 1150: 300-310.
36. Manirarora JN, Kosiewicz MM, Parnell SA, Alard P (2008) APC activation restores functional CD4(+)CD25(+) regulatory T cells in NOD mice that can prevent diabetes development. PLoS ONE 3(11):e3739.
37. Savage NDL, et al. (2008) Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1. J Immunol 181(3): 2220-2226.
38. Bending D, et al. (2009) Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 119(3): 565-572.
39. McGeachy MJ, et al. (2007) TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8(12): 1390-1397.
40. Peng H, Hagopian W (2006) Environmental factors in the development of Type 1 diabetes. Rev Endocr Metab Disord 7(3): 149-162.
41. Yuen KC, Chong LE, Riddle MC (2013) Influence of glucocorticoids and growth hormone on insulin sensitivity in humans. Diabet Med 30(6): 651-663.
42. Hill DJ, Petrik J, Arany E, McDonald TJ, Delovitch TL (1999) Insulin-like growth factors prevent cytokine-mediated cell death in isolated islets of Langerhans from prediabetic non-obese diabetic mice. J Endocrinol 161(1): 153-165.
43. Whittaker PG, Taylor KW (1980) Direct effects of rat growth hormone in rat islets of langerhans in tissues culture. Diabetologia 18(4): 323-328.
44. Rhodes CJ (2000) IGF-I and GH post-receptor signaling mechanisms for pancreatic beta-cell replication. J Mol Endocrinol 24(3): 303-311.
45. Flodström-Tullberg M, et al. (2003) Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse. Diabetes 52(11): 2696-2700.
46. Jackerott M, et al. (2006) STAT5 activity in pancreatic beta-cells influences the severity of diabetes in animal models of type 1 and 2 diabetes. Diabetes 55(10): 2705-2712.
47. Clark R (1997) The somatogenic hormones and insulin-like growth factor-1: Stimulators of lymphopoiesis and immune function. Endocr Rev 18(2): 157-179.
48. Alard P, et al. (2006) Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice. Diabetes 55(7): 2098-2105.
49. Serreze DV, et al. (1998) B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 161(8): 3912-3918.
50. Wan YY, Flavell RA (2007) Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445(7129): 766-770.
51. Gebert CA, Park SH, Waxman DJ (1997) Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation. Mol Endocrinol 11(4): 400-414.
52. Pallandre J-R, et al. (2007) Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: Implications in graft-versus-host disease and antitumor immunity. J Immunol 179(11): 7593-7604.
53. Chen BJ, et al. (2010) Growth hormone mitigates against lethal irradiation and enhances hematologic and immune recovery in mice and nonhuman primates. PLoS ONE 5(6):e11056.
54. Martinez FO, Sica A, Mantovani A, Locati M (2008) Macrophage activation and polarization. Front Biosci 13: 453-461.
55. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3(1): 23-35.
56. Zizzo G, Cohen PL (2013) IL-17 stimulates differentiation of human anti-inflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids. J Immunol 190(10): 5237-5246.
57. Komiyama Y, et al. (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177(1): 566-573.
58. Hirota K, et al. (2007) Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 204(12): 2803-2812.
59. Ghoreschi K, Laurence A, Yang XP, Hirahara K, O'Shea JJ (2011) T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. Trends Immunol 32(9): 395-401.
60. Marwaha AK, Leung NJ, McMurchy AN, Levings MK (2012) TH17 Cells in Autoimmunity and Immunodeficiency: Protective or pathogenic? Front Immunol 3:129.
61. Wang R, et al. (2007) The role of STAT3 in antigen-IgG inducing regulatory CD4(+)Foxp3(+)T cells. Cell Immunol 246(2): 103-109.
62. Gaba A, et al. (2012) Cutting edge: IL-10-mediated tristetraprolin induction is part of a feedback loop that controls macrophage STAT3 activation and cytokine production. J Immunol 189(5): 2089-2093.
63. Hoang PT, et al. (2010) The neurosurvival factor Humanin inhibits beta-cell apoptosis via signal transducer and activator of transcription 3 activation and delays and ameliorates diabetes in nonobese diabetic mice. Metabolism 59(3): 343-349.
64. Mori H, et al. (2007) Suppression of SOCS3 expression in the pancreatic beta-cell leads to resistance to type 1 diabetes. Biochem Biophys Res Commun 359(4): 952-958.
65. Cecim M, Kerr J, Bartke A (1995) Effects of bovine growth hormone (bGH) transgene expression or bGH treatment on reproductive functions in female mice. Biol Reprod 52(5): 1144-1148.
66. Dietrich WF, et al. (1996) A comprehensive genetic map of the mouse genome. Nature 380(6570): 149-152.
67. Montanya E, Téllez N (2009) Pancreatic remodeling: Beta-cell apoptosis, proliferation and neogenesis, and the measurement of beta-cell mass and of individual beta-cell size. Methods Mol Biol 560: 137-158.
68. Ye J, et al. (2012) Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13:134.